Synapse - Raajit Rampal

Results (351)

Cytokine modulation correlates strongly with symptom improvement in patients with myelofibrosis treated with nuvisertib (TP-3654), an investigational selective PIM1 kinase inhibitor

Meeting Abstract

Rein, L. A. M.; El Chaer, F.; Yuda, J.; Shimoda, K.; Rampal, R.; Scandura, J. M.; Takami, A.; McCloskey, J.; Ichii, M.; Shirane, S.; more...
Blood (2024)

Fulltext@MSK | Save

Improvement in serum albumin as a measure of improved metabolic profile in pacritinib-treated patients: A retrospective analysis of patients treated across three clinical trials

Meeting Abstract

Palandri, F.; Sobas, M.; Harrison, C.; Rampal, R.; Buckley, S.; Suthar, P.; Roman-Torres, K.; Mascarenhas, J. O.
Blood (2024)

Fulltext@MSK | Save

Updated results from the phase 3 MANIFEST-2 study of pelabresib in combination with ruxolitinib for Janus kinase inhibitor-naive patients with myelofibrosis

Meeting Abstract

Mascarenhas, J. O.; Grosicki, S.; Chraniuk, D.; Abruzzese, E.; Bose, P.; Gerds, A. T.; Vannucchi, A. M.; Palandri, F.; Lee, S. E.; Gupta, V.; more...
Blood (2024)

Fulltext@MSK | Save

Efficacy of a novel BCL-XL degrader, DT2216, in preclinical models of post-myeloproliferative neoplasm secondary AML

Meeting Abstract

Wang, Z.; Skwarska, A.; Poigailwar, G.; Chaudhry, S.; Rodriguez-Meira, A.; Sui, P.; Olivier, E.; Jia, Y.; Ramage, C. L.; Zheng, G.; more...
Blood (2024)

Fulltext@MSK | Save

Crebbp inhibition potentiates JAK2 inhibition in post-MPN acute myeloid leukemia

Meeting Abstract

Bertulfo, K.; Miller, H.; Najac, R.; Castelan, J. C.; Ma, C.; Debackere, K.; Xiao, W.; Rampal, R.; Levine, R. L.; Lu, C.; more...
Blood (2024)

Fulltext@MSK | Save

Outcomes of patients with IDH1/2 mutated accelerated/blast-phase myeloproliferative neoplasms in the era of IDH inhibitors

Meeting Abstract

Goldberg, L. A.; Yoon, J. J.; Johnston, H.; Davidson, M. B.; Siddon, A.; Shallis, R. M.; Chen, E. C.; Burkart, M.; Oh, T. S.; Iyer, S. G.; more...
Blood (2024)

Fulltext@MSK | Save

Ocular findings in patients with histiocytosis and association with clinical and molecular features

Journal Article

Francis, J. H.; Reiner, A. S.; Canestraro, J.; Rampal, R. K.; Abramson, D. H.; Diamond, E. L.
British Journal of Ophthalmology (2024)

Fulltext@MSK | Save

A phase 1 trial of valemetostat in patients with relapsed or refractory (R/R) acute myeloid leukemia (AML) or acute lymphocytic leukemia (ALL)

Meeting Abstract

Erba, H. P.; Oluwole, O. O.; Bixby, D.; Rampal, R. K.; Fathi, A. T.; Paliwal, P.; Jin, J.; Inoue, A.; Daver, N.
Clinical Lymphoma, Myeloma and Leukemia (2024)

Fulltext@MSK | Save

Pelabresib plus ruxolitinib combination therapy in jak inhibitor-naïve patients with myelofibrosis in the phase 3 MANIFEST-2 study: Preliminary evidence of bone marrow recovery